Nobody will know the difference, and nobody will ask
Z79.84 for long-term oral hypoglycemic use Drug-Induced Obesity (E66.1) Medications that commonly cause iatrogenic weight gain include: antipsychotics (olanzapine, clozapine, quetiapine), corticosteroids (E66.1 + adverse effect T code), insulin, certain antidepressants (tricyclics, mirtazapine), valproic acid, and lithium
Heres how different groups responded to treatment: Race and Ethnicity : Clinical benefits were consistent across all racial and ethnic groups Type 2 Diabetes : Patients without diabetes achieved higher total body weight loss (16.9%) versus those with diabetes (9.9%) at 12 months Body Mass Index (BMI) : After two years of treatment, 52.4% of participants moved down at least one BMI category Results show that 12% of adults receiving semaglutide reached a healthy BMI of 25 kg/m or less, compared to only 1.2% in the placebo group
The study is organized by Scripps Research and aims to enroll 1000 participants